Kang Qian

机构：Nantong University, Nantong Maternity and Child Health Hospital, Kindeva Drug Delivery (United States)

发表论文 41 篇 · 总被引 1191 次 · h-index 18

代表论文

• Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease (2022 · ACS Nano · 被引 84)
• Revisiting the critical roles of reactive astrocytes in neurodegeneration (2023 · Molecular Psychiatry · 被引 83)
• Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease (2023 · Journal of Controlled Release · 被引 35)
• Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery (2023 · Journal of Nanobiotechnology · 被引 27)
• Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer’s Disease (2024 · ACS Nano · 被引 26)
• Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis (2023 · Acta Pharmaceutica Sinica B · 被引 22)